SIRT1 was observed to redress the imbalance of tissue inhibitor of matrix metalloproteinase-1 and matrix metalloproteinase-9 in the development of mouse emphysema and human COPD (166). This evidence concerns the gene SIRT1 and chronic obstructive pulmonary disease.